Navigating the complex landscape of drug discovery requires innovative strategies and interdisciplinary collaborations spanning biotechnology, pharmacology, medicine and engineering. As the cost of developing new drugs surges, the pharmaceutical industry is increasingly driven to explore the potential of artificial intelligence and machine learning technologies to reshape research, expedite timelines and curtail costs. Yet, amid this promising innovation lie potential intellectual property…
By: Foley & Lardner LLP
By: Foley & Lardner LLP
